Piperacillin/Tazobactam (ZOSYN)
1997

Piperacillin/Tazobactam for Gynecologic Infections

Sample size: 2261 publication Evidence: moderate

Author Information

Author(s): Stephanie M. Culver, Mark G. Martens

Primary Institution: Hennepin County Medical Center

Hypothesis

Piperacillin/tazobactam is an effective treatment for gynecologic infections.

Conclusion

Piperacillin/tazobactam is an effective and well-tolerated regimen for treating gynecologic infections.

Supporting Evidence

  • Piperacillin/tazobactam has a broad spectrum of activity against various pathogens.
  • Only 3.2% of patients experienced adverse effects that required stopping treatment.
  • The combination showed comparable efficacy to clindamycin/gentamicin in treating pelvic infections.
  • Clinical responses were favorable in 85% of patients treated with piperacillin/tazobactam.

Takeaway

Piperacillin/tazobactam is a medicine that helps treat infections in women, and it works well without causing many side effects.

Methodology

The study involved clinical trials comparing piperacillin/tazobactam with other antibiotic regimens in treating gynecologic infections.

Potential Biases

Potential bias in reporting adverse effects and efficacy due to the nature of clinical trials.

Limitations

The study may not cover all possible side effects or long-term outcomes of using piperacillin/tazobactam.

Participant Demographics

The study included 2,261 patients with various gynecologic infections.

Statistical Information

P-Value

0.001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication